FF
DNA icon

Fluent Financial’s Ginkgo Bioworks DNA Stock Holding History

Fluent Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-338
Closed -$4.51K – 65
2024
Q2 		$4.51K Hold
338
– – ﹤0.01% 72
2024
Q1 		$15.7K Sell
338
-37
-10% -$1.92K 0.01% 85
2023
Q4 		$25.4K Sell
375
-25
-6% -$1.53K 0.02% 74
2023
Q3 		$29K Hold
400
– – 0.02% 81
2023
Q2 		$29.8K Hold
400
– – 0.02% 78
2023
Q1 		$21.3K Buy
+400
New +$25.3K 0.01% 62
2022
Q3 		– Sell
-250
Closed -$24K – 66
2022
Q2 		$24K Buy
+250
New +$30.5K 0.01% 65

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fluent Financial's DNA Position: Q3 2024 in Review

Fluent Financial sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 338 shares — an estimated $4.51K sold.

Fluent Financial first reported a position in DNA in Q2 2022 and held it in 7 quarters. The position peaked at $29.8K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Fluent Financial reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Fluent Financial sold 338 Ginkgo Bioworks shares in Q3 2024, an estimated $4.51K.
  • Fluent Financial first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 7 quarters.
  • Fluent Financial's Ginkgo Bioworks position peaked at $29.8K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Fluent Financial's 13F filing for Q3 2024, filed 4 Oct 2024.